STOCK TITAN

First Light, Mathew Arens report 3.62M Axogen holdings (AXGN)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Axogen, Inc. ownership update: First Light Asset Management, LLC and Mathew P. Arens jointly report beneficial ownership stakes in Axogen common stock via a Schedule 13G/A (Amendment No. 3).

First Light reports 3,291,463 shares (6.19%) and Mr. Arens reports 3,617,993 shares (6.80%), including 187,000 shares held solely by Mr. Arens. The filing is a joint statement per Item 2 and includes a Joint Filing Agreement.

Positive

  • None.

Negative

  • None.
First Light shares 3,291,463 shares beneficially owned per Schedule 13G/A
First Light percent 6.19% percent of class reported by First Light
Arens shares 3,617,993 shares beneficially owned per Schedule 13G/A
Arens percent 6.80% percent of class reported by Mathew P. Arens
Arens sole voting shares 187,000 shares sole voting and sole dispositive power held directly by Mr. Arens
Schedule 13G/A regulatory
"jointly filed by the following: First Light Asset Management, LLC"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficial ownership financial
"may be deemed to be the beneficial owner of 3,291,463"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared dispositive power regulatory
"Shared Dispositive Power 3,291,463.00"
Joint Filing Agreement legal
"Exhibit A: Joint Filing Agreement"





05463X106

(CUSIP Number)
04/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



First Light Asset Management, LLC
Signature:/s/ Kurt T. Peterson
Name/Title:Kurt T. Peterson/Chief Compliance Officer
Date:05/07/2026
Mathew P. Arens
Signature:/s/ Mathew P. Arens
Name/Title:Mathew P. Arens/Chief Executive Officer
Date:05/07/2026
Exhibit Information

Exhibit A: Joint Filing Agreement

FAQ

What stake does First Light Asset Management report in Axogen (AXGN)?

First Light Asset Management reports beneficial ownership of 3,291,463 shares, representing 6.19% of Axogen's common stock. The Manager's reported holdings reflect shared voting and dispositive power across managed accounts and certain private funds as stated in the filing.

How many Axogen shares does Mathew P. Arens report owning?

Mathew P. Arens reports beneficial ownership of 3,617,993 shares, representing 6.80% of common stock. That total includes 187,000 shares held with sole voting and dispositive power and additional shares held with shared power.

Do First Light and Mr. Arens file this ownership jointly?

Yes. The filing is a joint Schedule 13G/A submitted by First Light Asset Management, LLC and Mathew P. Arens. The filing includes a Joint Filing Agreement and states the Manager and Mr. Arens may be deemed beneficial owners as described in Item 2.

What voting or dispositive powers are reported for these holdings?

First Light reports 0 sole voting and 3,291,463 shared voting and dispositive powers. Mr. Arens reports 187,000 sole voting and dispositive and 3,430,993 shared voting and dispositive powers, per Item 4 of the filing.

Does the filing state any intent to buy or sell Axogen shares?

No trading intent is stated. The Schedule 13G/A discloses beneficial ownership and allocation of voting/dispositive powers; it does not state any planned purchases or sales or any change in holdings beyond the reported totals.